These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27746582)

  • 1. Optical manipulation of a single human virus for study of viral-cell interactions.
    Hou X; DeSantis MC; Tian C; Cheng W
    Proc SPIE Int Soc Opt Eng; 2016 Aug; 9922():. PubMed ID: 27746582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
    Pandori MW; Fitch NJ; Craig HM; Richman DD; Spina CA; Guatelli JC
    J Virol; 1996 Jul; 70(7):4283-90. PubMed ID: 8676450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for tethering single viral particles for virus-cell interaction studies with optical tweezers.
    Schimert KI; Cheng W
    Proc SPIE Int Soc Opt Eng; 2018 Aug; 10723():. PubMed ID: 30872888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
    J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.
    Rossio JL; Esser MT; Suryanarayana K; Schneider DK; Bess JW; Vasquez GM; Wiltrout TA; Chertova E; Grimes MK; Sattentau Q; Arthur LO; Henderson LE; Lifson JD
    J Virol; 1998 Oct; 72(10):7992-8001. PubMed ID: 9733838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using optical trap to measure the refractive index of a single animal virus in culture fluid with high precision.
    Pang Y; Song H; Cheng W
    Biomed Opt Express; 2016 May; 7(5):1672-89. PubMed ID: 27231613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between HIV-1 Gag and Viral RNA Genome Enhance Virion Assembly.
    Dilley KA; Nikolaitchik OA; Galli A; Burdick RC; Levine L; Li K; Rein A; Pathak VK; Hu WS
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virion-targeted viral inactivation: new therapy against viral infection.
    Okui N; Kitamura Y; Kobayashi N; Sakuma R; Ishikawa T; Kitamura T
    Mol Urol; 2001; 5(2):59-66. PubMed ID: 11690549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.
    Schaeffer E; Geleziunas R; Greene WC
    J Virol; 2001 Mar; 75(6):2993-3000. PubMed ID: 11222724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical trapping of individual human immunodeficiency viruses in culture fluid reveals heterogeneity with single-molecule resolution.
    Pang Y; Song H; Kim JH; Hou X; Cheng W
    Nat Nanotechnol; 2014 Aug; 9(8):624-30. PubMed ID: 25038779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material.
    Tardif MR; Tremblay MJ
    J Virol; 2003 Nov; 77(22):12299-309. PubMed ID: 14581566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
    Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
    J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts.
    Graham DR; Chertova E; Hilburn JM; Arthur LO; Hildreth JE
    J Virol; 2003 Aug; 77(15):8237-48. PubMed ID: 12857892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.
    Cantin R; Fortin JF; Lamontagne G; Tremblay M
    J Virol; 1997 Mar; 71(3):1922-30. PubMed ID: 9032323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells.
    Mengistu M; Ray K; Lewis GK; DeVico AL
    PLoS Pathog; 2015 Mar; 11(3):e1004772. PubMed ID: 25807494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHX9/RHA Binding to the PBS-Segment of the Genomic RNA during HIV-1 Assembly Bolsters Virion Infectivity.
    Boeras I; Song Z; Moran A; Franklin J; Brown WC; Johnson M; Boris-Lawrie K; Heng X
    J Mol Biol; 2016 Jun; 428(11):2418-2429. PubMed ID: 27107641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced Packaging of Cellular MicroRNAs into HIV-1 Virions Can Inhibit Infectivity.
    Bogerd HP; Kennedy EM; Whisnant AW; Cullen BR
    mBio; 2017 Jan; 8(1):. PubMed ID: 28096489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.
    Burrer R; Haessig-Einius S; Aubertin AM; Moog C
    J Virol; 2003 Nov; 77(21):11385-97. PubMed ID: 14557624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.
    Zhou J; Aiken C
    J Virol; 2001 Jul; 75(13):5851-9. PubMed ID: 11390586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5.
    Staropoli I; Dufloo J; Ducher A; Commere PH; Sartori-Rupp A; Novault S; Bruel T; Lorin V; Mouquet H; Schwartz O; Casartelli N
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.